Breast Neoplasms

SEP 9, 2026 · PHASE 1/2 TRIAL

A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer

ClinicalTrials.gov

This is an active Phase 1/2 trial registration with no results posted; enrollment is complete but outcomes have not been reported in this registry record.

SEP 9, 2026 · INTERVENTIONAL STUDY

CT-AI Breast Cancer Opportunistic Screening Health Examination Study

ClinicalTrials.gov

This is a registered but not-yet-recruiting prospective single-arm implementation study with no reported results; it describes a planned evaluation of an AI screening device without efficacy or safety data.

SEP 9, 2026 · INTERVENTIONAL STUDY

Single-Fraction Very Accelerated Partial Breast Irradiation (sfVAPBI)

ClinicalTrials.gov

This is an active registry record for an interventional study with no reported results; it describes a planned investigation of a novel single-fraction radiation approach in early breast cancer.

SEP 8, 2026 · PHASE 3 TRIAL

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

ClinicalTrials.gov

This is a clinical trial registry record describing a Phase 3 RCT that is currently recruiting with no results posted; the study design is rigorous but outcomes are not yet available.

SEP 8, 2026 · PHASE 3 TRIAL

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

ClinicalTrials.gov

This is a Phase 3 RCT registration with no results posted; the study is actively recruiting and designed to test a novel PIK3CA inhibitor in advanced breast cancer, but outcome data are not yet available.

SEP 4, 2026 · OBSERVATIONAL STUDY

BRCA Mutations in Latinas

ClinicalTrials.gov

This is a completed observational registry study with no posted results; it describes enrollment and biospecimen collection methodology only, without outcome data or analysis.

AUG 20, 2026 · PHASE 2 TRIAL

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

ClinicalTrials.gov

This is a Phase 1/2A open-label, non-randomized safety and tolerability study of an investigational agent; no results are reported in this registry record.

AUG 14, 2026 · OBSERVATIONAL STUDY

Paclitaxel-induced Polyneuropathy in Breast Cancer: Early Detection, Risk Factors, Quality of Life and Lifestyle Outcomes

ClinicalTrials.gov

This is a withdrawn observational registry record with no posted results; it describes a planned study design and outcomes but contains no data to evaluate.